<?xml version="1.0" encoding="UTF-8"?>
<p id="p0150">Live influenza virus seed stocks were obtained from the International Reagent Resource (IRR; 
 <ext-link ext-link-type="uri" xlink:href="http://www.internationalreagentresource.org" id="intref0050" xmlns:xlink="http://www.w3.org/1999/xlink">www.internationalreagentresource.org</ext-link>) and grown in MDCK or MDCK-SIAT1 cultures (approximately 40 million cells per virus) in MEM medium supplemented with, 2 mM L-Glutamine and 100 U mL
 <sup>-1</sup> of Penicillin-Streptomycin. Cell cultures were washed twice in warm PBS prior to the addition of virus, typically diluted 1:1000 in growth medium. Diluted virus was incubated with cell cultures for 1 hour before being removed and replaced with growth medium supplemented with 2 μg mL
 <sup>-1</sup> tosyl phenylalanyl chloromethyl ketone (TPCK)-trypsin and further incubated for 72 h. At day 3, culture supernatant was recovered and centrifuged at 1000x g to remove cell debris before final centrifugation at 65,000x g for 2 hours at 4
 <sup>°</sup>C to isolate viral pellets. Viral pellets were resuspended in 1 mL PBS supplemented with 5% (w/v) sterile glycerol, aliquoted, and stored at -80
 <sup>o</sup>C. For measuring virus titer by the TCID50 (median tissue culture infectious dose) assay, MDCK or MDCK-SIAT1 cells were washed twice with PBS prior to the addition of virus, and viral growth medium supplemented with 2 μg mL
 <sup>-1</sup> TPCK-trypsin. For measuring viral HA titers (median hemagglutination), virus stocks were diluted in PBS and an equal volume of 0.5% turkey red blood cells added. A/New Caledonia/20/1999 (
 <xref rid="bib10" ref-type="bibr">Chen et al., 2011</xref>) and A/Anhui/1/2013 (
 <xref rid="bib30" ref-type="bibr">Imai et al., 2017</xref>) aliquots were obtained in BPL-inactivated (beta-propiolactone) form and only characterized by HA titers.
</p>
